申请人:BASF Aktiengesellschaft
公开号:US06342604B1
公开(公告)日:2002-01-29
The present invention relates to the use of pyrimidine compounds of the following formula:
wherein R1, R2, R3, A, B and Ar have the meanings indicated in the description. The compounds according to the invention have a high affinity for the dopamine D3 receptor and can therefore be used to treat disorders which respond to dopamine D3 ligands.
本发明涉及以下式的嘧啶化合物的使用:其中R1、R2、R3、A、B和Ar的含义如描述中所示。根据本发明的化合物具有高亲和力与多巴胺D3受体,因此可用于治疗对多巴胺D3配体产生反应的疾病。